Effects of Specific Thoracic Spine Mobilizations on Muscle Activity in a Healthy Volunteer Population

NCT ID: NCT06374862

Last Updated: 2025-05-25

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

156 participants

Study Classification

INTERVENTIONAL

Study Start Date

2024-03-28

Study Completion Date

2025-10-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

In this study, the investigators will examine the effect of manual therapy on the thoracic spine and its impact on the muscular strength gain of the thoracic extensors. Treatment with manual therapy, as described by Maitland, consists of a specific mobilization of the thoracic spine in the postero-anterior direction on the transverse and spiny processes of the thoracic vertebrae. To ensure the relevance of the measures, and to better control the occurrence of biases inherent to the practice of manual therapy, the investigators constituted three distinct groups: an intervention group, a control group and a group without intervention. In short, this methodology will allow us to explore in detail the effects of specific spinal mobilization on motor control, while taking into account placebo response elements and natural variations in the results

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Musculoskeletal Manipulations Range of Motion Muscle Strength Peripheral Joints in Upper Quarters

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

OTHER

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Interventional

This study is of an interventional nature, because the investigators want to objectively assess the impact of specific mobilization on neuromuscular functioning, thanks to surface EMG, before and after a specific mobilization of the spine.

Group Type EXPERIMENTAL

mobilization

Intervention Type OTHER

specific mobilization on neuromuscular functioning, thanks to surface EMG, before and after a specific mobilization of the spine

control

This approach will help to determine whether there is spontaneous modulation of neuromuscular activity in the absence of intervention. Thus, the investigators can distinguish the effects of intervention from natural variations in the healthy subject.

Group Type SHAM_COMPARATOR

no effect

Intervention Type OTHER

a mobilization identified as "no effect" could modulate neuromuscular activity by a placebo effect.

no interventional

A control group was also integrated to assess whether a mobilization identified as "no effect" could modulate neuromuscular activity by a placebo effect. This approach will allow to disentangle the real effects of mobilization from those that could result from psychomotor responses

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

mobilization

specific mobilization on neuromuscular functioning, thanks to surface EMG, before and after a specific mobilization of the spine

Intervention Type OTHER

no effect

a mobilization identified as "no effect" could modulate neuromuscular activity by a placebo effect.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Ages 18 to 65,
* healthy volunteer,
* membership in a social security scheme

Exclusion Criteria

* Severe spinal trauma within the last 6 months
* history of low back pain, back pain, and/or neck pain within the last 6 months,
* history of spinal surgery,
* history of chronic systemic disease (cardiac, respiratory, diabetes, etc.),
* volunteer with Pacemaker, history of rheumatological pathology (rheumatoid arthritis, ankylosing spondylitis, Scheuermann's disease, etc.),
* patient under guardianship,curatorship, safeguard of justice, patient deprived of liberty, pregnant woman and patient without Red Flags Social Security described in literature.
Minimum Eligible Age

18 Years

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Centre Hospitalier Universitaire, Amiens

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

CHU Amiens Picardie

Amiens, Picardie, France

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

France

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Vicente BELTRAN AIBAR

Role: CONTACT

03 22 45 59 92

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Vicente BELTRAN AIBAR

Role: primary

03.22.45.59.92

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

PI2024_843_0008

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.